Highlights from the plenary session: eosinophilic granulomatosis with polyangiitis and hypereosinophilic syndrome.

 0 Người đánh giá. Xếp hạng trung bình 0

Tác giả: Julia U Holle, Augusto Vaglio

Ngôn ngữ: eng

Ký hiệu phân loại: 940.5472 1918

Thông tin xuất bản: England : Rheumatology (Oxford, England) , 2025

Mô tả vật lý:

Bộ sưu tập: NCBI

ID: 698422

Hypereosinophilic syndrome (HES) and eosinophilic granulomatosis with polyangiitis (EGPA) both present with hypereosinophilia and organ damage induced by eosinophils. EGPA is also characterized by vasculitis and is associated with ANCA. Yet, discriminating HES from EGPA may be difficult in clinical practice as biomarkers to reliably differentiate between HES and EGPA are still lacking. In recent years, it has been demonstrated that targeting IL-5 is efficacious to treat HES and EGPA, and the use of anti-IL-5(R)-antibodies has become a mainstay of therapy in HES and these diseases. Nonetheless, it remains unclear whether anti-IL-5 strategies are sufficient to treat organ-threatening eosinophilic manifestations or vasculitic manifestations in EGPA.
Tạo bộ sưu tập với mã QR

THƯ VIỆN - TRƯỜNG ĐẠI HỌC CÔNG NGHỆ TP.HCM

ĐT: (028) 36225755 | Email: tt.thuvien@hutech.edu.vn

Copyright @2024 THƯ VIỆN HUTECH